comparemela.com
Latest Breaking News On - Imdc risk score - Page 1 : comparemela.com
Considerations in Advanced RCC Treatment Selection
Pedro Barata, MD, MSc, and Benjamin Garmezy, MD, outline factors taken into consideration when selecting advanced RCC treatments.
United-states
American
Benjamin-garmezy
Pedro-barata
Sloan-kettering
Memorial-sloan-kettering
African-american
Renal-cell-carcinoma
Io-tkis
Immunotherapy
Sunitinib
Patient Profile: A 67-Year-Old Man With Metastatic Clear Cell RCC
Benjamin Garmezy, MD, presents the case of a 67-year-old man diagnosed with advanced renal cell carcinoma.
Pedro-barata
Benjamin-garmezy
Renal-cell-carcinoma
Metastatic-clear-cell-rcc
Imdc-intermediate-risk
Imdc-risk-score
Doublet-immunotherapy
Io-tkis
Clear-trial
Lenvatinib
Pembrolizumab
vimarsana © 2020. All Rights Reserved.